NATURAL VITAMIN E FORMS AS ANTI-INFLAMMATORY DRUGS

天然维生素 E 形式作为抗炎药物

基本信息

  • 批准号:
    7062439
  • 负责人:
  • 金额:
    $ 33.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-15 至 2007-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic inflammation constitutes one of the major etiologies of degenerative diseases including cancer, and cardiovascular and neurodegenerative diseases; chronic inflammation also contributes to rheumatoid arthritis, asthma and hepatitis. These diseases are among the leading causes of death and disability in the world. During inflammation, several pro-inflammatory mediators including prostaglandin E2 (PGE2) and leukotriene B4 (LTB4), as well as cytokines, such as TNF-alpha, play central roles in regulating inflammatory response and inflammation-mediated damage. Vitamin E comprises eight structurally related molecules, alpha-,beta-, gamma-, delta-tocopherol, and alpha-,beta-, gamma-, delta -tocotrienol. Among them, only alpha -tocopherol (alphaT) has been extensively studied. Recent studies indicate that other forms of vitamin E have unique properties, which are not shared by alphaT, but are important to human disease prevention and therapy. Gamma-Tocopherol (gammaT) and its metabolite, but not aT, exhibit anti-inflammatory effects by inhibiting cyclooxygenase (COX)- catalyzed formation of PGE2. In a rat inflammation model, gammaT inhibits not only PGE2, but also LTB4, and TNF-alpha. These results suggest that gammaT may be superior to some commonly used non-steroid anti-inflammatory drugs (NSAIDs), such as COX inhibitors, most of which only inhibit the COX-mediated pathway. Preliminary studies also indicate that delta- tocopherol and gamma-tocotrienol, compared with gammaT, are even stronger inhibitors of the COX-catalyzed formation of PGE2. These observations led to the current hypothesis that certain forms of vitamin E and their combinations have unique pharmaceutical utility as anti-inflammatory drugs, or as supplements that complement and improve current treatments for inflammatory diseases. This hypothesis will be tested by pursuit of the following Specific Aims in cell culture and animal experiments: 1. Investigate in vitro anti-inflammatory properties of individual vitamin E forms and their combinations; 2. Investigate and compare in vivo anti-inflammatory activities of individual vitamin E forms and their combinations; and 3. Investigate the potentially improved effects of combining certain forms of vitamin E and NSAIDs, such as aspirin, in a rat inflammation model. Our studies may lead to the discovery of novel and better therapy for treating and preventing inflammatory diseases, and provide the scientific rationale, the experimental evidence and the biochemical basis for future human studies.
描述(申请人提供):慢性炎症是包括癌症、心血管和神经退行性疾病在内的退行性疾病的主要病因之一;慢性炎症还会导致类风湿性关节炎、哮喘和肝炎。这些疾病是世界上导致死亡和残疾的主要原因之一。在炎症过程中,前列腺素E_2(PGE_2)和白三烯B_4(LTB_4)等促炎介质以及细胞因子(如肿瘤坏死因子-α)在调节炎症反应和炎症介导的损伤中发挥核心作用。维生素E由八个结构相关的分子组成,分别是α-、β-、γ-、β-生育酚和α-、β-、γ-、β-生育三烯酚。其中,只有α-生育酚(AlphaT)得到了广泛的研究。最近的研究表明,其他形式的维生素E具有独特的特性,这些特性是AlphaT所没有的,但对人类疾病的预防和治疗很重要。γ-生育酚(GammaT)及其代谢产物,但不是At,通过抑制环氧合酶(COX)催化的PGE2的形成而显示出抗炎作用。在大鼠炎症模型中,GammaT不仅抑制PGE2,还抑制LTB4和TNF-α。这些结果表明,GammaT可能优于一些常用的非类固醇抗炎药(NSAIDs),如COX抑制剂,它们大多只抑制COX介导的途径。初步研究还表明,与GammaT相比,β-生育酚和γ-生育三烯酚对COX催化的PGE2的形成具有更强的抑制作用。这些观察结果导致了目前的假设,即某些形式的维生素E及其组合作为消炎药或作为补充和改善目前炎症性疾病治疗的补充剂具有独特的药用价值。这一假设将通过在细胞培养和动物实验中追求以下特定目标来验证:1.研究个别维生素E形式及其组合的体外抗炎特性;2.调查和比较单独的维生素E形式及其组合的体内抗炎活性;以及3.调查某些形式的维生素E与非甾体抗炎药(如阿司匹林)在大鼠炎症模型中的潜在改善效果。我们的研究可能会发现治疗和预防炎症性疾病的新的更好的治疗方法,并为未来的人类研究提供科学的理论基础、实验证据和生化基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Qing Jiang其他文献

Qing Jiang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Qing Jiang', 18)}}的其他基金

Anti-inflammatory mechanisms, pharmacokinetics of novel metabolites of vitamin E
维生素E新型代谢物的抗炎机制、药代动力学
  • 批准号:
    8196666
  • 财政年份:
    2011
  • 资助金额:
    $ 33.44万
  • 项目类别:
The Role of a Novel Vitamin E Metabolite in Colon Cancer Prevention and Therapy
新型维生素 E 代谢物在结肠癌预防和治疗中的作用
  • 批准号:
    8230605
  • 财政年份:
    2011
  • 资助金额:
    $ 33.44万
  • 项目类别:
Anti-inflammatory mechanisms, pharmacokinetics of novel metabolites of vitamin E
维生素E新型代谢物的抗炎机制、药代动力学
  • 批准号:
    8326747
  • 财政年份:
    2011
  • 资助金额:
    $ 33.44万
  • 项目类别:
The Role of a Novel Vitamin E Metabolite in Colon Cancer Prevention and Therapy
新型维生素 E 代谢物在结肠癌预防和治疗中的作用
  • 批准号:
    8099210
  • 财政年份:
    2011
  • 资助金额:
    $ 33.44万
  • 项目类别:
Gamma-tocopherol as an effective anticancer agent for colon cancer
γ-生育酚作为结肠癌的有效抗癌剂
  • 批准号:
    7752828
  • 财政年份:
    2009
  • 资助金额:
    $ 33.44万
  • 项目类别:
Gamma-tocopherol as an effective anticancer agent for colon cancer
γ-生育酚作为结肠癌的有效抗癌剂
  • 批准号:
    7580180
  • 财政年份:
    2009
  • 资助金额:
    $ 33.44万
  • 项目类别:
NATURAL VITAMIN E FORMS AS ANTI-INFLAMMATORY DRUGS
天然维生素 E 形式作为抗炎药物
  • 批准号:
    6801784
  • 财政年份:
    2003
  • 资助金额:
    $ 33.44万
  • 项目类别:
NATURAL VITAMIN E FORMS AS ANTI-INFLAMMATORY DRUGS
天然维生素 E 形式作为抗炎药物
  • 批准号:
    7076096
  • 财政年份:
    2003
  • 资助金额:
    $ 33.44万
  • 项目类别:
NATURAL VITAMIN E FORMS AS ANTI-INFLAMMATORY DRUGS
天然维生素 E 形式作为抗炎药物
  • 批准号:
    7010222
  • 财政年份:
    2003
  • 资助金额:
    $ 33.44万
  • 项目类别:

相似海外基金

Cannabinoid Acids as Antiinflammatory Agents
大麻素酸作为抗炎剂
  • 批准号:
    6665391
  • 财政年份:
    2002
  • 资助金额:
    $ 33.44万
  • 项目类别:
Cannabinoid Acids as Antiinflammatory Agents
大麻素酸作为抗炎剂
  • 批准号:
    6797921
  • 财政年份:
    2002
  • 资助金额:
    $ 33.44万
  • 项目类别:
New Antiinflammatory Agents to Prevent Damage to Islets
防止胰岛损伤的新型抗炎剂
  • 批准号:
    6576060
  • 财政年份:
    2002
  • 资助金额:
    $ 33.44万
  • 项目类别:
Cannabinoid Acids as Antiinflammatory Agents
大麻素酸作为抗炎剂
  • 批准号:
    6573795
  • 财政年份:
    2002
  • 资助金额:
    $ 33.44万
  • 项目类别:
New Antiinflammatory Agents to Prevent Damage to Islets
防止胰岛损伤的新型抗炎剂
  • 批准号:
    6665374
  • 财政年份:
    2002
  • 资助金额:
    $ 33.44万
  • 项目类别:
Effects of nonsteroidal antiinflammatory agents on thyroid hormone levels
非甾体抗炎药对甲状腺激素水平的影响
  • 批准号:
    6465857
  • 财政年份:
    2000
  • 资助金额:
    $ 33.44万
  • 项目类别:
ROLE OF NONSTEROIDAL ANTIINFLAMMATORY AGENTS IN OUTCOME OF OA
非甾体类抗炎药在 OA 结局中的作用
  • 批准号:
    6318272
  • 财政年份:
    2000
  • 资助金额:
    $ 33.44万
  • 项目类别:
CARIBBEAN CORALS (PSEUDOPTEROGORIA) AS SOURCE OF NEW ANTIINFLAMMATORY AGENTS)
加勒比珊瑚(PSEUDOPTEROGORIA)作为新型抗炎剂的来源)
  • 批准号:
    6219061
  • 财政年份:
    1999
  • 资助金额:
    $ 33.44万
  • 项目类别:
ROLE OF NONSTEROIDAL ANTIINFLAMMATORY AGENTS IN OUTCOME OF OA
非甾体类抗炎药在 OA 结局中的作用
  • 批准号:
    6100638
  • 财政年份:
    1999
  • 资助金额:
    $ 33.44万
  • 项目类别:
CARIBBEAN CORALS (PSEUDOPTEROGORIA) AS SOURCE OF NEW ANTIINFLAMMATORY AGENTS)
加勒比珊瑚(PSEUDOPTEROGORIA)作为新型抗炎剂的来源)
  • 批准号:
    6107139
  • 财政年份:
    1998
  • 资助金额:
    $ 33.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了